BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 96 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,754 | -99.6% | 94,000 | +164.8% | 0.00% | +100.0% |
| Q3 2022 | $420,000 | -42.8% | 35,500 | -36.2% | 0.00% | 0.0% |
| Q2 2022 | $734,000 | +86.8% | 55,600 | +195.7% | 0.00% | – |
| Q1 2022 | $393,000 | -95.2% | 18,800 | -87.9% | 0.00% | -100.0% |
| Q2 2020 | $8,248,000 | +409.1% | 155,600 | +114.6% | 0.01% | +250.0% |
| Q1 2020 | $1,620,000 | +48.1% | 72,500 | -3.2% | 0.00% | +100.0% |
| Q4 2019 | $1,094,000 | +100.0% | 74,900 | -3.6% | 0.00% | – |
| Q3 2019 | $547,000 | -30.3% | 77,700 | +8.5% | 0.00% | -100.0% |
| Q2 2019 | $785,000 | +77.2% | 71,600 | +59.8% | 0.00% | – |
| Q1 2019 | $443,000 | – | 44,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |